Exiqon together with the Interdisciplinary Melanoma Program (IMCG) at the NYU
Cancer Institute announces presentation of results at the 2011 ASCO Annual
meeting showing the use of microRNAs as biomarkers in melonama.

Exiqon A/S (Copenhagen: EXQ) today announced the presentation of results from
its diagnostic program together with the Interdisciplinary Melanoma Program
(IMCG) at the NYU Cancer Institute on the potential of using circulating
microRNAs in serum for prognostic purposes in melanoma has been selected for
presentation at the 2011 ASCO meeting to be held June 3-6 in Chicago.

In the absence of curative therapy for patients with metastatic melanoma, the
early identification of patients at high risk for the development of aggressive
disease is critical. The stability of miRNAs in routinely collected clinical
blood derived serum samples makes miRNAs excellent targets in the search for
non-invasive cancer biomarkers. The results to be presented support the
potential of serum miRNAs as diagnostic and prognostic biomarkers in melanoma.

The title of the presentation is: “An analysis of sera-based microRNAs as
biomarkers of recurrence in melanoma”. Abstract No: 8513, Citation: J Clin
Oncol 29: 2011 (suppl; abstr 8513) will be presented on Monday, June 6 at
11:30am.

“The data presented using qPCR screening highlights again the potential of
miRNAs as robust biomarkers in blood serum. We are very excited to be working
with one of the most recognized world leading melanoma programs at NYU and we
look forward to pushing this program forward during 2011”, said Adam Baker, VP
of Diagnostics at Exiqon.

For more information, visit the 2011 ASCO Annual Meeting home page at:
http://chicago2011.asco.org/

Additional information:

Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)

Adam Baker, Vice President Diagnostics & Pharmaceutical Alliances, email:
[email protected], tel. +45 4565 0986 (cell: +45 4090 2153)

Please see the full announcement in the enclosed pdf-file.

Announcement_15_2011_ASCO_NYU.pdf